After strategic market research indicated that there was increasing demand for treatments for breast cancer, Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) saw a sharp increase in
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) concluded its Friday’s trading session with a modest 2.8% gain, leaving investors to be cautiously optimistic. However, the post-closing activity
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.